TiGenix Archives -

Japanese pharma giant Takeda has completed its buyout of TiGenix. Takeda’s main R&D focus is in oncology, gastroenterology

Takeda finalises buyout of TiGenix

https://pharmaphorum.com/news/japanese-takeda-finalises-tigenix-boyout/

Decision follows EU regulators’ decision to back Crohn’s stem cell therapy

Takeda to buy stem cell specialists TiGenix for $626m

https://pharmaphorum.com/news/takeda-buy-gastro-biotech-tigenix-463m/

Alofisel recommended for complex perianal fistulas in Crohn’s disease

First ever ‘off the shelf’ stem cell therapy nears European approval

https://pharmaphorum.com/news/tigenixtakeda-stem-cell-therapy-backed-eu-regulators/

TiGenix